Time to Invest in L...
Health Care: Drugs
Horizon Pharma Inc (HZNP: NASDAQ)
$2.39 0.00 | 0.00%
05/23/13 - 04:00 PM ET
Portfolios with HZNP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- Usersuziltd
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Facing FDA Ap...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest HZNP Headlines from TheStreet
- 3 Stocks Under $10 Making Big Moves 03.15.13 | 07:03 am
- January Effect Stock Picks Here Are 7 Possible Winners For 2013 12.28.12 | 03:12 pm
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- 5 Stocks Insiders Love Right Now 10.03.12 | 01:10 pm
- Horizon Pharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.10.12 | 02:08 pm
- Biotech Stock Mailbag: Amarin, Sarepta 07.27.12 | 06:07 am
- Horizon Pharma: Rayos FDA Approval Thursday Seems Likely 07.25.12 | 10:07 am
- 28 Drugs Facing FDA Approval in 2012-2013 07.24.12 | 07:07 am
Press Releases for HZNP
- Horizon Pharma Announces Completion Of Sales Force Expansion - PR Newswire 10.01.12 | 07:10 am
- Horizon Pharma Announces Receipt Of Two Additional U.S. Patent Allowances For DUEXIS® - PR Newswire 09.28.12 | 07:09 am
- Horizon Pharma Announces FDA Approval Of RAYOS® (prednisone) Delayed-Release Tablets For Rheumatoid Arthritis And Multiple Additional Indications - PR Newswire 07.26.12 | 04:07 pm
- The Grünenthal Group Enters Into Exclusive Agreement With Horizon Pharma For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 08:06 am
- Horizon Pharma Enters Into Exclusive Agreement With Grunenthal For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 07:06 am
- Horizon Pharma And Mallinckrodt, The Pharmaceuticals Business Of Covidien, Enter Into Co-Promotion Agreement For DUEXIS® In The United States - PR Newswire 06.18.12 | 06:06 am
- Horizon Pharma Announces Issuance Of U.S. Patent Covering RAYOS (delayed-release Prednisone) - PR Newswire 05.29.12 | 07:05 am
Partner Headlines for HZNP
- Pre-Market Earnings Report for March 18, 2013 : KIOR, IMOS, NMRX, TA, HWCC, INSM, AMRC, PTX, STRL, HZNP, UTSI, DEXO - NASDAQ 03.15.13 | 08:03 pm
- The January Effect And 3 Biopharma Stocks - Seeking Alpha 11.09.12 | 09:11 am
- From Earlier: Horizon Pharma Announces US Patent for Rayos Tablet - Benzinga 10.15.12 | 09:10 am
- Huge Insider Buy Makes This $3.50 Biopharma Stock An Intriguing Speculative Play - Seeking Alpha 10.07.12 | 08:10 am
- Morning Market Losers - Benzinga 09.20.12 | 01:09 pm
- A Pullback Would Be Healthy For Repros Therapeutics - Seeking Alpha 09.20.12 | 09:09 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- 6 Healthcare Stocks With Pending August Catalysts - Seeking Alpha 08.01.12 | 09:08 am
- 4 Hot Healthcare Stocks Making Mid-Week Noise - Seeking Alpha 07.25.12 | 09:07 am
- Earnings Preview: Covidien - Analyst Blog - Zacks 07.23.12 | 10:07 am
